Dual HDAC and PI3K Inhibitor: A Novel Potential Therapeutic Option in Cushing Disease. - 2021

Available online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006


English

0021-972X

10.1210/clinem/dgaa845 [doi] 5986702 [pii]


*Phosphatidylinositol 3-Kinases
*Pituitary ACTH Hypersecretion
Histone Deacetylase Inhibitors/tu [Therapeutic Use]
Humans
Phosphoinositide-3 Kinase Inhibitors
Pituitary ACTH Hypersecretion/dt [Drug Therapy]


MedStar Washington Hospital Center


Medicine/Endocrinology


Journal Article